Postvaccination C-Reactive Protein and C5/gp41732–744Antibody Level Fold-Changes Over Baseline Are Independent Predictors of Therapeutic HIV Vaccine Effect in a Phase 2 Clinical Study of Vacc-4x-Reference-Cited by-同舟云学术

Postvaccination C-Reactive Protein and C5/gp41732–744Antibody Level Fold-Changes Over Baseline Are Independent Predictors of Therapeutic HIV Vaccine Effect in a Phase 2 Clinical Study of Vacc-4x

Published:2018-03 Issue:3 Volume:34 Page:307-313
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Huang Yunda¹²,Zhang Lily¹,Jolliffe Darren³,Sanchez Brittany¹,Stjernholm Grete⁴,Jelmert Øyvind⁵,Ökvist Mats⁴,Sommerfelt Maja A.⁴

Affiliation:

1. Division of Vaccine and Infectious Disease, Fred Hutchinson Cancer Research Center, Seattle, Washington.

2. Department of Global Health, University of Washington, Seattle, Washington.

3. S-Cubed Biometrics, Ltd., Oxfordshire, United Kingdom.

4. Bionor Pharma AS, Oslo, Norway.

5. Bionor Laboratories AS, Skien, Norway.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2017.0179

Reference24 articles.

1. Re-emergence of HIV after stopping therapy

2. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

3. HIV therapeutic vaccines: moving towards a functional cure

4. Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with Antiviral Drugs Will Significantly Inhibit the HIV-1 RNA POL Gene Expression and Viral Load in AIDS Patients;Disease Markers;2023-04-14

2. Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response;Vaccines;2020-08-05

3. Biovacc-19: A Candidate Vaccine for Covid-19 (SARS-CoV-2) Developed from Analysis of its General Method of Action for Infectivity;QRB Discovery;2020

4. Acute phase protein response to viral infection and vaccination;Archives of Biochemistry and Biophysics;2019-08

5. Computational analysis in designing T cell epitopes enriched peptides of Ebola glycoprotein exhibiting strong binding interaction with HLA molecules;Journal of Theoretical Biology;2019-03